Latham & Watkins represented the underwriters in the IPO. IO Biotech, Inc. has announced the pricing of its initial public offering of 7,150,000 shares of its common...
IO Biotech’s $100.1 Million Initial Public Offering
Pyxis Oncology’s $168 Million Upsized Initial Public Offering
Latham & Watkins represented the underwriters in the offering. Pyxis Oncology, Inc., a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target...
Walgreens’ US$5.2 Billion Investment in VillageMD
Sidley Austin advised Walgreens Boots Alliance on the deal, while Latham & Watkins represented VillageMD. Wilmer Cutler Pickering Hale and Dorr represented Kinnevik. Walgreens Boots Alliance signed...
Neogames’s $145 Million Secondary Offering
Herzog Fox & Neeman and Latham & Watkins advised Neogames on the deal. NeoGames S.A., a provider of online gaming technology and services to lottery operators,...
Global-e Online’s $883 Million Shares Offering
Latham & Watkins advised Global-e Online on the deal, while Gornitzky represented the underwriters. Global-e Online Ltd. announced the pricing of its underwritten secondary offering by certain...
ZOLL Medical’s $538 Million Acquisition of Itamar Medical
Latham & Watkins and Goldfarb Seligman & Co. represented Itamar Medical in the transaction. Cooley and Gornitzky & Co. advised ZOLL Medical. Itamar™ Medical Ltd. (Nasdaq...
Memic Innovative Surgery’s Business Combination MedTech Acquisition Corporation
Greenberg Traurig represented Memic, while Foley & Lardner represented MedTech. Latham & Watkins represented the placement agents. Memic Innovative Surgery Ltd., a medical device company dedicated...
Immuneering’s US$129.4 Million IPO
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
Alpha Tau’s Business Combination with Healthcare Capital Corp.
Latham & Watkins LLP represented Alpha Tau in the transaction, while Winston & Strawn represented the placement agent. Alpha Tau Medical Limited, the developer of the...
Zentalis Pharmaceuticals’ $150.4 Million Common Stock Offering
Latham & Watkins LLP represented Zentalis Pharmaceuticals in the offering. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting...
Monte Rosa Therapeutics’ $222.3 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. Monte Rosa Therapeutics, Inc. executed its initial public offering of 11,700,000 shares of common stock at a...
WalkMe’s $287 Million Initial Public Offering
Latham & Watkins LLP represented WalkMe in the offering. WalkMe Ltd., a leading provider of digital adoption solutions, has announced the pricing of its initial public...